Knowledge, attitude, practice and barriers towards pharmacovigilance and adverse drug reactions reporting among healthcare professionals in Turkey: a systematic review

References

• Alwhaibi M, Al Aloola NA. Healthcare students’ knowledge, attitude and perception of pharmacovigilance: a systematic review. PLoS One. 2020;15(5):e0233393.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Pharmacovigilance. 2021. Available from: https://www.who.int/medicines/areas/quality_safety/safety_efficacy/pharmvigi/en/.
   Google Scholar
• 18th ISoP Annual Meeting “Pharmacovigilance without borders” Geneva, Switzerland. 2018. Drug Saf. 2018;41:1103–273..
   Google Scholar
• Khan Z, Karataş Y, Rahman H. Adverse drug reactions reporting in Turkey and barriers: an urgent need for pharmacovigilance education. Ther Adv Drug Saf. 2020;11:204209862092243–204209862092248.
   Web of Science ®Google Scholar
• World Health Organization (WHO). Quality Assurance and Safety of Medicines Team. Safety of medicines: a guide to detecting and reporting adverse drug reactions: why health professionals need to take action. 2002. Available from: https://apps.who.int/iris/handle/10665/67378.
   Google Scholar
• Nisa ZU, Zafar A, Sher F. Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the Capital of Pakistan. Saudi Pharm J. 2018;26(4):453–461.
   PubMed Web of Science ®Google Scholar
• Insani WN, Whittlesea C, Alwafi H, et al. Prevalence of adverse drug reactions in the primary care setting: a systematic review and Meta-analysis. PLoS One. 2021;16(5):e0252161..
   PubMed Web of Science ®Google Scholar
• Gidey K, Seifu M, Hailu BY, et al. Healthcare professionals knowledge, attitude and practice of adverse drug reactions reporting in Ethiopia: a cross-sectional study. BMJ Open. 2020;10(2):e034553.
   PubMed Web of Science ®Google Scholar
• Khalil H, Huang C. Adverse drug reactions in primary care: a scoping review. BMC Health Serv Res. 2020;20(1):5–13..
   PubMed Web of Science ®Google Scholar
• Al-Hamid A, Ghaleb M, Aljadhey H, et al. A systematic review of hospitalization resulting from medicine-related problems in adult patients. Br J Clin Pharmacol. 2014;78(2):202–217.
   PubMed Web of Science ®Google Scholar
• Watanabe JH, McInnis T, Hirsch JD. Cost of prescription drug-related morbidity and Mortality. Ann Pharmacother. 2018;52(9):829–837.
   PubMed Web of Science ®Google Scholar
• Sultana J, Cutroneo P, Trifirò G. Clinical and economic burden of adverse drug reactions. J Pharmacol Pharmacother. 2013;4(Suppl 1):S73–S77.
   PubMedGoogle Scholar
• Formica D, Sultana J, Cutroneo PM, et al. The economic burden of preventable adverse drug reactions: a systematic review of observational studies. Expert Opin Drug Saf. 2018;17(7):681–695.
   PubMed Web of Science ®Google Scholar
• Oshikoya KA, Chukwura H, Njokanma OF, et al. Incidence and cost estimate of treating pediatric adverse drug reactions in Lagos, Nigeria. Sao Paulo Med J. 2011;129(3):153–164.
   PubMed Web of Science ®Google Scholar
• Gyllensten H, Rehnberg C, Jönsson AK, et al. Cost of illness of patient-reported adverse drug events: a population-based cross-sectional survey. BMJ Open. 2013;3(6):e002574.
   PubMed Web of Science ®Google Scholar
• Al Damen L, Basheti I. Preventability analysis of adverse drug reactions in a Jordanian hospital: a prospective observational study. Int J Clin Pharm. 2019;41(6):1599–1610.
   PubMed Web of Science ®Google Scholar
• Giardina C, Cutroneo PM, Mocciaro E, et al. Adverse drug reactions in hospitalized patients: results of the FORWARD (Facilitation of Reporting in Hospital Ward) Study. Front Pharmacol. 2018;9:350.
   PubMed Web of Science ®Google Scholar
• World Health Organization (WHO). Reporting and learning systems for medication errors: the role of pharmacovigilance centres. 2014. Available from: https://apps.who.int/iris/handle/10665/137036.
   Google Scholar
• Ergün Y, Ergün TB, Toker E, et al. Knowledge attitude and practice of Turkish health professionals towards pharmacovigilance in a university hospital. Int Health. 2019;11(3):177–184.
   PubMed Web of Science ®Google Scholar
• Haines HM, Meyer JC, Summers RS, et al. Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district. Eur J Clin Pharmacol. 2020;76(7):991–1001.
   PubMed Web of Science ®Google Scholar
• Gordhon Y, Padayachee N. Evaluating the knowledge, attitudes and practices of healthcare workers towards adverse drug reaction reporting at a public tertiary hospital in Johannesburg. Int J Afr Nurs Sci. 2020;12:100191..
   Google Scholar
• Ali I, Ahmad W, Ullah AR, et al. Knowledge, attitude, and barriers toward ADRs reporting among health-care professionals at tertiary care health settings in Peshawar, Pakistan: a web based study. Hosp Pharm. 2021;56(4):384–391.
   PubMed Web of Science ®Google Scholar
• Adisa R, Omitogun TI. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria. BMC Health Serv Res. 2019;19(1):926..
   PubMed Web of Science ®Google Scholar
• Bepari A, Niazi SK, Rahman I, et al. The comparative evaluation of knowledge, attitude, and practice of different health-care professionals about the pharmacovigilance system of India. J Adv Pharm Technol Res. 2019;10(2):68–74.
   PubMed Web of Science ®Google Scholar
• AlShammari TM, Almoslem MJ. Knowledge, attitudes & practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: a multi-Centre cross sectional study. Saudi Pharm J. 2018;26(7):925–931.
   PubMed Web of Science ®Google Scholar
• Alsaleh FM, Alzaid SW, Abahussain EA, et al. Knowledge, attitude and practices of pharmacovigilance and adverse drug reaction reporting among pharmacists working in secondary and tertiary governmental hospitals in Kuwait. Saudi Pharm J. 2017;25(6):830–837.
   PubMed Web of Science ®Google Scholar
• Nadew SS, Beyene KG, Beza SW. Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia. PLoS One. 2020;15(1):e0227712. Published 2020 Jan 21.
   PubMed Web of Science ®Google Scholar
• Olsson S, Pal SN, Stergachis A, et al. Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis . Drug Saf. 2010;33(8):689–703..
   PubMed Web of Science ®Google Scholar
• Katusiime B, Semakula D, Lubinga SJ. Adverse drug reaction reporting among health care workers at mulago national referral and teaching hospital in Uganda. Afr Health Sci. 2015;15(4):1308–1317.
   PubMed Web of Science ®Google Scholar
• Tandon VR, Mahajan V, Khajuria V, et al. Under-reporting of adverse drug reactions: a challenge for pharmacovigilance in India. Indian J Pharmacol. 2015;47(1):65–71.
   PubMed Web of Science ®Google Scholar
• Dweik RA, Yaya S, Stacey D, et al. Spontaneous adverse drug reaction reporting by patients in Canada: a multi-method study-study protocol. Springerplus. 2016;5:213.
   PubMedGoogle Scholar
• Cheema E, Haseeb A, Khan TM, et al. Barriers to reporting of adverse drugs reactions: a cross sectional study among community pharmacists in United Kingdom. Pharm Pract (Granada). 2017;15(3):931.
   PubMed Web of Science ®Google Scholar
• Hailu AD, Mohammed SA. Adverse drug reaction reporting in Ethiopia: systematic review. Biomed Res Int. 2020;2020:8569314.
   PubMed Web of Science ®Google Scholar
• Le TT, Nguyen TTH, Nguyen C, et al. Factors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam. J Clin Pharm Ther. 2020;45(1):122–127.
   PubMed Web of Science ®Google Scholar
• Turkey Pharmaceuticals and Medical Devices Agency, Legislation on Drug Safety Official Gazette. No: 28973. 2014. [Turkish: Türkiye İlaç ve Tıbbi Cihaz Kurumu, İlaçların Güvenliliği Hakkında Yönetmelik Resmi Gazete. 2014. Sayı: 28973] Available from: http://www.resmigazete.gov.tr/eskiler/2014/04/20140415-6.htm.
   Google Scholar
• Güner MD, Ekmekci PE. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess. 2019;8(1):13–20.
   PubMed Web of Science ®Google Scholar
• Khan Z, Öz E, Kıroğlu O, et al. Analysis of adverse drug reactions in hospitalized patients reported to pharmacovigilance center in a teaching hospital. Cukurova Medical Journal. 2020;45(2):556–561..
   Google Scholar
• Karataş Y, Khan Z, Gören ÖE, et al. Knowledge, attitude and practices about pharmacovigilance and adverse drug reactions among dental research assistants in a Turkish hospital: a cross-sectional study. J Health Sci Med. 2020;3(4):367–371..
   Google Scholar
• Ozcan G, Aykac E, Kasap Y, et al. Adverse drug reaction reporting pattern in Turkey: analysis of the national database in the context of the first pharmacovigilance legislation. Drugs Real World Outcomes. 2016;3(1):33–43.
   PubMedGoogle Scholar
• Turkey Pharmaceuticals and Medical Devices Agency, (TPDMA) Administration Annual Report 2020. Number of adverse reaction reports sent to WHO. Page 108. Available from: https://www.titck.gov.tr/kurumsal/faaliyetraporu. [Turkish: Türkiye İlaç ve Tıbbi Cihaz Kurumu, İdare Faaliyet Raporu (2020), DSÖ’ye gönderilen advers reaksiyon bildirimi sayısı. Sayfa 108].
   Google Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Alan S, Ozturk M, Gokyildiz S, et al. An evaluation of knowledge of pharmacovigilance among nurses and midwives in Turkey. Indian J Pharmacol. 2013;45(6):616–618.
   PubMed Web of Science ®Google Scholar
• Tiftik N, Duman İ, Ün İ. Evaluation of knowledge, attitude and practices of nurses working in a university hospital about pharmacovigilance. Mersin Univ Sch Med Lokman Hekim J Hist Med Folk Med. 2019;9(3):285–293.. [Turkish: Tiftik N, Duman İ, Ün İ. Bir Üniversite Hastanesinde Görev Yapan Hemşirelerin Farmakovijilans Hakkında Bilgi, Tutum ve Uygulamalarının Değerlendirmesi. Mersin Üniversitesi Tıp Fakültesi Lokman Hekim Tıp Tarihi ve Folklorik Tıp Dergisi. 2019; 9(3): 285-293].
   Google Scholar
• Vural F, Ciftci S, Vural B. The knowledge, attitude and behaviours of nurses about pharmacovigilance, adverse drug reaction and adverse event reporting in a state hospital. North Clin Istanb. 2014;1(3):147–152.
   PubMedGoogle Scholar
• Çadırcı D, Oğuz E, Koçakoğlu Ş, et al. Knowledge and attitudes of resident physicians about adverse drug reactions. Konuralp Med J. 2020;12(3):498–502.
   Google Scholar
• Von Elm E, Altman DG, Egger M, et al. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61(4):344–349..
   PubMed Web of Science ®Google Scholar
• Agarwald A, Guyatt G, Busse J. Methods commentary: risk of bias in cross-sectional surveys of attitudes and preferences; 2019. p. 3–7. https://www.evidencepartners.com/wp-content/uploads/2017/04/Methods-Commentary-Risk-of-Bias-in-cross-sectional-surveys-of-attitude.pdf.
   Google Scholar
• Aydin OC, Aydin S, Guney HZ. Pharmacovigilance and radiologists: How well do they get along? Br J Radiol. 2020;93(1115):20200596
   PubMed Web of Science ®Google Scholar
• Kaya S, Karaman S, Demir İ, et al. Attitudes and barriers to incident reporting for doctors and nurses in a university hospital’s surgery departments. J Basic Clin Health Sci. 2020;4:108–113.
   Web of Science ®Google Scholar
• Aydınkarahaliloğlu ND, Aykaç E, Atalan Ö, et al. Spontaneous reporting of adverse drug reactions by consumers in comparison with healthcare professionals in Turkey from 2014 to 2016. Pharm Med. 2018;32(5):353–364..
   Web of Science ®Google Scholar
• Gumustekin M, Arici MA, Koca P, Gelal A, et al. Impact of an educational intervention on knowledge and attitude related to adverse drug reactions reported by physicians in an university hospital. Clin Ther. 2017;39(8):E59–E60.
   Google Scholar
• Şencan N, Altınkaynak M, Ferah İ, et al. The knowledge and attitudes of physicians and nurses towards adverse event reporting and the effect of pharmacovigilance training: a hospital experience. Hacettepe Univ J Facul Pharm. 2010;30(1):25–40.
   Google Scholar
• Bhagavathula AS, Elnour AA, Jamshed SQ, et al. Health professionals’ knowledge, attitudes and practices about pharmacovigilance in India: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0152221.
   PubMed Web of Science ®Google Scholar
• Reumerman M, Tichelaar J, Piersma B, et al. Urgent need to modernize pharmacovigilance education in healthcare curricula: review of the literature. Eur J Clin Pharmacol. 2018;74(10):1235–1248.
   PubMed Web of Science ®Google Scholar
• Turkey pharmacovigilance center (TÜFAM). 2005. Available from: https://titck.gov.tr/PortalAdmin/Uploads/UnitPageAttachment/QSl4TS8m.pdf.
   Google Scholar
• Beckmann J, Hagemann U, Bahri P, et al. Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum. Drug Saf. 2014;37(10):743–759.
   PubMed Web of Science ®Google Scholar
• Khan SA, Goyal C, Tonpay SD. A study of knowledge, attitudes, and practice of dental doctors about adverse drug reaction reporting in a teaching hospital in India. Perspect Clin Res. 2015;6(3):144–149.
   PubMedGoogle Scholar
• Shrestha S, Sharma S, Bhasima R, et al. Impact of an educational intervention on pharmacovigilance knowledge and attitudes among health professionals in a Nepal cancer hospital. BMC Med Educ. 2020;20(1):179..
   PubMed Web of Science ®Google Scholar
• Türkiye İlaç ve Tıbbi Cihaz Kurumu, İdare Faaliyet Raporu 2019. DSÖ’ye gönderilen advers reaksiyon bildirimi sayısı. Sayfa 96 [Turkey Pharmaceuticals and Medical Devices Agency, Administration Annual Report (2019), Number of adverse reaction reports sent to WHO. Page 96]. https://www.titck.gov.tr/kurumsal/faaliyetraporu.
   Google Scholar
• Radecka A, Loughlin L, Foy M, et al. Enhancing pharmacovigilance capabilities in the EU regulatory network: the SCOPE joint Action. Drug Saf. 2018; 41(12):1285–1302.
   PubMed Web of Science ®Google Scholar
• Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385–396.
   PubMed Web of Science ®Google Scholar
• Kraus CN, Baldwin AT, McAllister RG. Improving the effect of FDA-mandated drug safety alerts with internet-based continuing medical education. Curr Drug Saf. 2013;8(1):11–16.
   PubMedGoogle Scholar
• Aygin BE, Kutay D. Opinions of community pharmacists about collaboration with general practitioners: a descriptive pilot study after new legislation in Turkey. Turk J Pharm Sci. 2018;15:212–218.
   PubMed Web of Science ®Google Scholar